Literature DB >> 19572400

Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system.

Sirika Pillay1, Ann Meyers, Anna-Lise Williamson, Edward P Rybicki.   

Abstract

A baculovirus-insect cell expression system potentially provides the means to produce prophylactic HIV-1 virus-like particle (VLP) vaccines inexpensively and in large quantities. However, the system must be optimized to maximize yields and increase process efficiency. In this study, we optimized the production of two novel, chimeric HIV-1 VLP vaccine candidates (GagRT and GagTN) in insect cells. This was done by monitoring the effects of four specific factors on VLP expression: these were insect cell line, cell density, multiplicity of infection (MOI), and infection time. The use of western blots, Gag p24 ELISA, and four-factorial ANOVA allowed the determination of the most favorable conditions for chimeric VLP production, as well as which factors affected VLP expression most significantly. Both VLP vaccine candidates favored similar optimal conditions, demonstrating higher yields of VLPs when produced in the Trichoplusia ni Pro insect cell line, at a cell density of 1 x 10(6) cells/mL, and an infection time of 96 h post infection. It was found that cell density and infection time were major influencing factors, but that MOI did not affect VLP expression significantly. This work provides a potentially valuable guideline for HIV-1 protein vaccine optimization, as well as for general optimization of a baculovirus-based expression system to produce complex recombinant proteins. (c) 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572400     DOI: 10.1002/btpr.187

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  10 in total

1.  From plant virology to vaccinology: The road less travelled.

Authors:  Edward Rybicki
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  HIV-1 sub-type C chimaeric VLPs boost cellular immune responses in mice.

Authors:  Sirika Pillay; Enid G Shephard; Ann E Meyers; Anna-Lise Williamson; Edward P Rybicki
Journal:  J Immune Based Ther Vaccines       Date:  2010-11-19

Review 3.  Current progress in the development of a prophylactic vaccine for HIV-1.

Authors:  Lena J Gamble; Qiana L Matthews
Journal:  Drug Des Devel Ther       Date:  2010-12-22       Impact factor: 4.162

4.  Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.

Authors:  Ziyaad Valley-Omar; Ann E Meyers; Enid G Shephard; Anna-Lise Williamson; Edward P Rybicki
Journal:  Virol J       Date:  2011-10-06       Impact factor: 4.099

5.  Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses.

Authors:  Ryoichi Shima; Tian Cheng Li; Yutaka Sendai; Chikako Kataoka; Yoshio Mori; Takayuki Abe; Naokazu Takeda; Toru Okamoto; Yoshiharu Matsuura
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

6.  Optimization of rPDT fusion protein expression by Escherichia coli in pilot scale fermentation: a statistical experimental design approach.

Authors:  Nasser Nassiri Koopaei; Parissa Khadiv-Parsi; Mohammad Reza Khoshayand; Mohammad Ali Mazlomi; Abbas Kebriaeezadeh; Hamid Moloudian; Roya Solhi; Mahdi Aminian
Journal:  AMB Express       Date:  2018-08-22       Impact factor: 3.298

Review 7.  Use of baculovirus expression system for generation of virus-like particles: successes and challenges.

Authors:  Fuxiao Liu; Xiaodong Wu; Lin Li; Zengshan Liu; Zhiliang Wang
Journal:  Protein Expr Purif       Date:  2013-06-03       Impact factor: 1.650

Review 8.  Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.

Authors:  Natasha Kushnir; Stephen J Streatfield; Vidadi Yusibov
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

Review 9.  Large-scale production and purification of VLP-based vaccines.

Authors:  Tiago Vicente; António Roldão; Cristina Peixoto; Manuel J T Carrondo; Paula M Alves
Journal:  J Invertebr Pathol       Date:  2011-07       Impact factor: 2.841

10.  Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells.

Authors:  Eduard Puente-Massaguer; Martí Lecina; Francesc Gòdia
Journal:  Appl Microbiol Biotechnol       Date:  2020-01-06       Impact factor: 4.813

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.